Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Neurogastroenterology and Motility
|
October 3, 2002
Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans
L Hidalgo, P Clavé, M Estorch, et al.
Gut
|
April 15, 2000
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans
D Matzinger, L Degen, J Drewe, et al.
International Journal of Clinical Practice
|
June 4, 2010
Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol
S Scholtissen, O Bruyère, A Neuprez, et al.
Journal of Biomedical Materials Research. Part A
|
January 11, 2025
A Bioprinted Hydrogel Patch With Bioactive Glass: A New Frontier in Chronic Wound Healing
T Petrachi, A Portone, D Bellucci, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
December 8, 2000
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause
M Stomati, P Monteleone, E Casarosa, et al.
Biomarker Research
|
January 9, 2021
Correction to: Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients
Antonio E Pontiroli, Lara Loreggian, Marco P L Rovati, et al.
Biomarker Research
|
March 28, 2017
Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients
Antonio E Pontiroli, Lara Loreggian, Marco P L Rovati, et al.
Osteoarthritis and Cartilage
|
June 14, 2001
Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers
E Vignon, P Garnero, P Delmas, et al.
Osteoarthritis and Cartilage
|
December 20, 2011
OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials
R L Manno, C O Bingham, S Paternotte, et al.
Osteoarthritis and Cartilage
|
March 15, 2011
Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis
J M Jordan, M F Sowers, S P Messier, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Neurogastroenterology and Motility
|
October 3, 2002
Effect of cholecystokinin-A receptor blockade on postprandial insulinaemia and gastric emptying in humans
L Hidalgo, P Clavé, M Estorch, et al.
Gut
|
April 15, 2000
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans
D Matzinger, L Degen, J Drewe, et al.
International Journal of Clinical Practice
|
June 4, 2010
Glucosamine sulphate in the treatment of knee osteoarthritis: cost-effectiveness comparison with paracetamol
S Scholtissen, O Bruyère, A Neuprez, et al.
Journal of Biomedical Materials Research. Part A
|
January 11, 2025
A Bioprinted Hydrogel Patch With Bioactive Glass: A New Frontier in Chronic Wound Healing
T Petrachi, A Portone, D Bellucci, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
December 8, 2000
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause
M Stomati, P Monteleone, E Casarosa, et al.
Biomarker Research
|
January 9, 2021
Correction to: Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients
Antonio E Pontiroli, Lara Loreggian, Marco P L Rovati, et al.
Biomarker Research
|
March 28, 2017
Length of hospitalization is associated with selected biomarkers (albumin and lymphocytes) and with co-morbidities: study on 4000 patients
Antonio E Pontiroli, Lara Loreggian, Marco P L Rovati, et al.
Osteoarthritis and Cartilage
|
June 14, 2001
Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers
E Vignon, P Garnero, P Delmas, et al.
Osteoarthritis and Cartilage
|
December 20, 2011
OARSI-OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials
R L Manno, C O Bingham, S Paternotte, et al.
Osteoarthritis and Cartilage
|
March 15, 2011
Methodologic issues in clinical trials for prevention or risk reduction in osteoarthritis
J M Jordan, M F Sowers, S P Messier, et al.
Page
of 8